AFFIRM (Atrial Fibrillation Follow-up Investigation of ...

Ankle-brachial index < 0.9 Exclusion Criteria: Type 1 diabetes. Calcitonin ≥50 ng/L . Use of a GLP-1 receptor agonist (exenatide, liraglutide or other) or pramlintide or any DPP-4 inhibitor within the 3 months prior to screening ................
................